BindingDB logo
myBDB logout

13 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
28222316 165 Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines.EBI De Montfort University
27687674 4 Targeting cytochrome P450 (CYP) 1B1 with steroid derivatives.EBI CHU de Qu£bec - Research Center (CHUL
27265259 16 Aryl morpholino triazenes inhibit cytochrome P450 1A1 and 1B1.EBI Whittier College
26222195 56 A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2.EBI Xavier University of Louisiana
25799264 94 Design and Synthesis of Newa-Naphthoflavones as Cytochrome P450 (CYP) 1B1 Inhibitors To Overcome Docetaxel-Resistance Associated with CYP1B1 Overexpression.EBI Shanghai Jiao Tong University
22863525 36 Design, synthesis and evaluation of the inhibitory selectivity of novel trans-resveratrol analogues on human recombinant CYP1A1, CYP1A2 and CYP1B1.EBI Poznan University of Medical Sciences
17544277 29 Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.EBI University of Maryland
12852960 48 Effect of structural modification on the inhibitory selectivity of rutaecarpine derivatives on human CYP1A1, CYP1A2, and CYP1B1.EBI National Research Institute of Chinese Medicine
21482471 28 Comparative CYP1A1 and CYP1B1 substrate and inhibitor profile of dietary flavonoids.EBI University of Crete
20696580 54 Selective inhibition of methoxyflavonoids on human CYP1B1 activity.EBI University of Shizuoka
11754588 39 Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors.EBI Seoul National University